Israel Englander Pacira Bio Sciences, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 345,625 shares of PCRX stock, worth $9.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

345,625

Previous 544,700 36.55%

Holding current value

$9.12 Million

Previous $10.3 Million 16.31%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$18.33 - $27.25 $20.9 Million - $31.1 Million	-1,139,887 Reduced 76.73%	345,625 $8.59 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $13.5 Million - $17.9 Million	879,473 Added 145.12%	1,485,512 $28 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $7.09 Million - $17.2 Million	606,039 New	606,039 $9.13 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $1.04 Million - $1.33 Million	37,448 New	37,448 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $57 Million - $75 Million	-1,578,969 Reduced 99.51%	7,774 $311,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $15.5 Million - $18.9 Million	434,989 Added 37.77%	1,586,743 $64.8 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $26.1 Million - $39.3 Million	683,680 Added 146.06%	1,151,754 $44.5 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $22.4 Million - $25.7 Million	436,699 Added 1391.87%	468,074 $24.9 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.62 Million - $2.56 Million	31,375 New	31,375 $1.83 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $7.95 Million - $10.1 Million	-132,483 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $3.05 Million - $3.96 Million	63,661 Added 92.5%	132,483 $7.97 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $4.3 Million - $4.83 Million	-78,765 Reduced 53.37%	68,822 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $1.97 Million - $2.33 Million	33,247 Added 29.08%	147,587 $8.96 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $1.68 Million - $2.24 Million	28,356 Added 32.98%	114,340 $8.01 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $100,687 - $132,188	1,995 Added 2.38%	85,984 $5.15 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $4.16 Million - $5.04 Million	80,059 Added 2037.12%	83,989 $5.05 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $5.07 Million - $8.63 Million	-164,524 Reduced 97.67%	3,930 $206,000
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $3.36 Million - $5.99 Million	-118,226 Reduced 41.24%	168,454 $5.65 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $12.8 Million - $16.5 Million	-352,459 Reduced 55.15%	286,680 $13 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $30.1 Million - $38 Million	-844,598 Reduced 56.92%	639,139 $24.3 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $14.3 Million - $18.7 Million	390,034 Added 35.66%	1,483,737 $64.5 Million
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $4.77 Million - $5.52 Million	-130,811 Reduced 10.68%	1,093,703 $41.6 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $8.45 Million - $10.7 Million	-204,456 Reduced 14.31%	1,224,514 $52.7 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $12.4 Million - $19.6 Million	376,467 Added 35.77%	1,428,970 $70.2 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $4.51 Million - $6.53 Million	164,112 Added 18.47%	1,052,503 $33.7 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $10.4 Million - $16.2 Million	348,542 Added 64.56%	888,391 $27.7 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $17.2 Million - $25.3 Million	539,849	539,849 $24.6 Million

Others Institutions Holding PCRX

# of Institutions

254

Shares Held

51.1M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.21B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account